1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3307)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11741)
  2. Survivorship Research (5670)
  3. Department of Medicine (5135)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3334)
  6. Surgery (2966)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (236)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11741)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Health-related quality of life (HRQOL) outcomes in arandomized controlled trial of yoga in breast and gynecological cancer survivors with chemotherapy-induced peripheral neuropathy
    Meeting Abstract

    Zhi, W. I.; Baser, R.; Zhi, L.; Piulson, L.; Li, Q.; Bao, T.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Emerging from COVID-19 pandemic: Provider perspective on use of neoadjuvant endocrine therapy (NET) in early stage hormone receptor positive breast cancer
    Meeting Abstract

    Park, K. U.; Gregory, M. E.; Lustberg, M. B.; Bazan, J. G.; Shen, C.; Rosenberg, S. M.; Blinder, V. S.; Sharma, P.; Pusztai, L.; Partridge, A. H.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase 1/2 clinical trial of a topical submicron particle paclitaxel (SOR007) for the treatment of cutaneous metastases
    Meeting Abstract

    Lacouture, M. E.; Lang, J. E.; Chawla, S.; Goldfarb, S.; Markova, A.; Pan, A.; Cavanna-Mast, R. M.; Mast, P.; Savoie, C.; diZerega, G.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Development of a breast cancer risk assessment model for ATM mutation carriers incorporating tyrer-cuzick and a polygenic risk score (PRS)
    Meeting Abstract

    Gallagher, S.; Hughes, E.; Rosenthal, E.; Kurian, A. W.; Domchek, S.; Garber, J.; Probst, B.; Morris, B.; Tshiaba, P.; Roa, B.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Fertility preservation in young women with breast cancer: Impact on treatment and outcomes
    Meeting Abstract

    Crown, A.; Muhsen, S.; Sevilimedu, V.; Kelvin, J.; Goldfarb, S. B.; Gemignani, M. L.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Pregnancy-associated breast cancer: Does timing of presentation affect outcome?
    Meeting Abstract

    Crown, A.; McCartan, D.; Curry, M.; Feldman, M.; Patil, S.; Kamer, S.; Goldfarb, S. B.; Gemignani, M.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • The optimal living and survivorship program: Piloting a novel cancer survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Clayton, J.; Smith, A.; Keenan, K.; Robson, M.; Iyengar, N.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Secondary outcomes in a randomized controlled trial of acupuncture versus sham acupuncture and usual care in solid tumor survivors with chemotherapy-induced peripheral neuropathy
    Meeting Abstract

    Bao, T.; Baser, R.; Lin, C.; Li, Q.; Piulson, L.; Zhi, I.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • KEYLYNK-009: A phase 2/3, open-label, randomized study of pembrolizumab plus olaparib vs pembrolizumab plus chemotherapy after induction with first-line pembrolizumab plus chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC)
    Meeting Abstract

    Rugo, H.; Llombart-Cussac, A.; Andre, F.; Robson, M. E.; Saji, S.; Harbeck, N.; Schmid, P.; Cescon, D.; Ahn, J. S.; Nanda, R.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • A phase 1b/2 study of the BET inhibitor ZEN003694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1/2 mutations
    Meeting Abstract

    Aftimos, P.; Oliveira, M.; Punie, K.; Boni, V.; Hamilton, E.; Gucalp, A.; Shah, P.; Mina, L.; Sharma, P.; Bauman, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save